Clinical Trials Logo

Clinical Trial Summary

Prospective, randomized, controlled, longitudinal, interventional multicentric study involving patients with reticular pseudodrusen secondary to AMD. The objective of this study is to establish the effectiveness of subthreshold laser treatment in increase/prevent the decrease of the retinal sensibility in patients with reticular pseudodrusen, and to reduce the progression of RPD to atrophy. Approximately 50 naïve patients with reticular pseudodrusen who underwent subthreshold laser treatment in perifoveal area. These patients should be randomized in the 2 study arms of the study. Patients will be evaluated at Screening/Baseline and then revaluated and retreated at month 3, 6 and 9. At month 12, all patients will be evaluated with a full ocular examination, visual acuity measurement (VA), optical coherence tomography (OCT) with autofluorescence, OCT-angiography and microperimetry. The rationale of the study is to prevent the evolution of reticular pseudodrusen to atrophic degeneration.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT04847635
Study type Interventional
Source Ospedale San Raffaele
Contact Giuseppe Querques, MD, PhD
Phone +390226434004
Email querques.giuseppe@hsr.it
Status Recruiting
Phase N/A
Start date March 16, 2021
Completion date September 1, 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03921931 - Retinal Photoreceptor Outer Segment Length Before and After Light Stimulation - a Pilot Study N/A
Not yet recruiting NCT04640649 - Prediction of Progression of Age-Related Macular Degeneration N/A
Completed NCT04084587 - Visual Rehabilitation Through Acoustic Biofeedback With Retimax Vision Trainer in Patients With Advanced Age-related Macular Degeneration N/A
Not yet recruiting NCT05418231 - Observation of the Natural Course of Age-related Macular Degeneration